<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.02">
 <iati-activity default-currency="CAD" hierarchy="1" iati-activities:version="2.02" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-301-2-108646-001</iati-identifier>
  <reporting-org ref="XM-DAC-301-2" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Modelling the impact of strategies to address the burden of sugary drinks consumption in Latin America and the Caribbean</narrative>
   <narrative xml:lang="FR">Mod&#xE9;lisation de l&#x2019;incidence des strat&#xE9;gies afin de r&#xE9;soudre la question du poids de la consommation de boissons sucr&#xE9;es en Am&#xE9;rique latine</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">Les maladies non transmissibles sont responsables de plus de la moiti&#xE9; de la charge mondiale de morbidit&#xE9;. L&#x2019;embonpoint et l&#x2019;ob&#xE9;sit&#xE9; font partie des principaux facteurs de risque modifiables &#xE0; l&#x2019;&#xE9;chelle mondiale, et leur pr&#xE9;valence augmente constamment en Am&#xE9;rique latine et dans les Cara&#xEF;bes. 

Les boissons sucr&#xE9;es constituent habituellement une importante source de calories facultatives et ont &#xE9;t&#xE9; associ&#xE9;es &#xE0; un risque accru d&#x2019;ob&#xE9;sit&#xE9;, au diab&#xE8;te de type 2, &#xE0; plusieurs cancers, &#xE0; l&#x2019;hypertension, &#xE0; la maladie cardiaque coronarienne et &#xE0; la carie dentaire. Pour ces raisons, beaucoup de pays songent ou ont commenc&#xE9; &#xE0; mettre en &#x153;uvre un ensemble de mesures visant &#xE0; r&#xE9;duire la consommation de boissons sucr&#xE9;es. 

La mise en &#x153;uvre de ces interventions doit &#xEA;tre soutenue par des donn&#xE9;es probantes scientifiques ad&#xE9;quates et exige l&#x2019;engagement de diff&#xE9;rentes parties prenantes afin d&#x2019;&#xEA;tre efficace. Toutefois, il y a un manque de donn&#xE9;es sur la charge de morbidit&#xE9; attribuable aux boissons sucr&#xE9;es et une absence d&#x2019;outils pour &#xE9;valuer l&#x2019;incidence potentielle des politiques. Ces facteurs entra&#xEE;nent un manque de consensus sur la n&#xE9;cessit&#xE9; d&#x2019;adopter de telles politiques et sur la priorit&#xE9; qui devrait leur &#xEA;tre accord&#xE9;e. 

L&#x2019;objectif de ce projet, mis en &#x153;uvre par l&#x2019;Instituto de Efectividad Clinica y Sanitaria Asociaci&#xF3;n Civil, d&#x2019;Argentine, est de combler ces besoins de renseignements en produisant des donn&#xE9;es probantes &#xE0; l&#x2019;&#xE9;chelle du pays sur la charge de morbidit&#xE9; attribuable &#xE0; la consommation de boissons sucr&#xE9;es et en compilant une base de connaissances sur les interventions possibles dans la r&#xE9;gion. L&#x2019;&#xE9;quipe de recherche &#xE9;laborera un mod&#xE8;le &#xE9;conomique pour estimer la charge de morbidit&#xE9; et la rentabilit&#xE9; de politiques pertinentes en Am&#xE9;rique latine et aux Cara&#xEF;bes. Le projet sera mis en &#x153;uvre et le mod&#xE8;le sera &#xE9;prouv&#xE9; en Argentine, au Br&#xE9;sil, au Salvador et &#xE0; Trinit&#xE9;-et-Tobago. 

Les r&#xE9;sultats de cette &#xE9;tude devraient favoriser l&#x2019;autonomisation des responsables des politiques afin de s&#xE9;lectionner le meilleur ensemble d&#x2019;interventions pour r&#xE9;duire la consommation de boissons sucr&#xE9;es et leur fardeau connexe en mati&#xE8;re de sant&#xE9; en Am&#xE9;rique latine et dans les Cara&#xEF;bes.</narrative>
   <narrative xml:lang="EN">Non-communicable diseases are responsible for more than half of the global burden of disease. Overweight and obesity are among the main modifiable risk factors worldwide and their prevalence has been steadily increasing in Latin America and the Caribbean. 

Sugar-sweetened beverages (SSBs) usually constitute a major source of discretionary calories, and have been linked to an increased risk of obesity, type 2 diabetes, several cancers, hypertension, coronary heart disease, and tooth decay. For these reasons, many countries are considering, or have begun implementing, a series of measures aimed at reducing SSB consumption. 

The implementation of these interventions needs to be supported by adequate scientific evidence and requires the commitment of different stakeholders in order to be successful. However, there is a lack of data on the burden of disease attributable to SSBs, and an absence of tools to assess the potential impact of policies. These factors result in a lack of consensus on the need to implement such policies and on the priority they should be given. 

The aim of this project, implemented by the Argentina-based Instituto de Efectividad Clinica y Sanitaria Asociaci&#xF3;n Civil is to fulfill these information needs by generating country-level evidence on the disease burdens attributable to SSB consumption and compiling a knowledge base on available interventions in the region. The research team will develop an economic model to estimate the disease burden and cost-effectiveness of relevant policies in Latin America and the Caribbean. The project will be carried out, and the model tested, in Argentina, Brazil, El Salvador, and Trinidad and Tobago. 

Results from this study are expected to empower decision-makers to select the best set of interventions to reduce the consumption of SSBs and their related health toll in Latin America and the Caribbean.</narrative>
  </description>
  <participating-org role="1" type="10">
   <narrative xml:lang="FR">Canada. Parlement</narrative>
   <narrative xml:lang="EN">Canada. Parliament</narrative>
  </participating-org>
  <participating-org role="2" type="22">
   <narrative xml:lang="ES">IECS - Instituto de Efectividad Clinica Y Sanitaria Asociacion Civil</narrative>
  </participating-org>
  <participating-org role="4" type="22">
   <narrative xml:lang="ES">IECS - Instituto de Efectividad Clinica Y Sanitaria Asociacion Civil</narrative>
  </participating-org>
  <participating-org role="3" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2018-03-01" type="2"></activity-date>
  <activity-date iso-date="2021-03-01" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
    <narrative xml:lang="EN">International Development Research Centre</narrative>
   </organisation>
   <telephone>(+1) 613-236-6163</telephone>
   <email>info@idrc.ca</email>
   <website>http://www.idrc.ca</website>
   <mailing-address>
    <narrative xml:lang="FR">CP 8500, Ottawa ON Canada, K1G 3H9</narrative>
    <narrative xml:lang="EN">PO Box 8500, Ottawa ON Canada, K1G 3H9</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="2"></activity-scope>
  <recipient-country code="AR" percentage="25"></recipient-country>
  <recipient-country code="BR" percentage="25"></recipient-country>
  <recipient-country code="SV" percentage="25"></recipient-country>
  <recipient-region code="380" percentage="25" vocabulary="1"></recipient-region>
  <sector code="1" percentage="100" vocabulary="99">
   <narrative xml:lang="FR">Autre</narrative>
   <narrative xml:lang="EN">Other</narrative>
  </sector>
  <sector code="12110" percentage="100" vocabulary="1"></sector>
  <policy-marker code="1" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="5" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="0" vocabulary="1"></policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2018-01-09"></transaction-date>
   <value currency="CAD" value-date="2018-01-09">787600</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="ES">IECS - Instituto de Efectividad Clinica Y Sanitaria Asociacion Civil</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2018-01-12"></transaction-date>
   <value currency="CAD" value-date="2018-01-12">166700</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="ES">IECS - Instituto de Efectividad Clinica Y Sanitaria Asociacion Civil</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2018-09-28"></transaction-date>
   <value currency="CAD" value-date="2018-09-28">166500</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="ES">IECS - Instituto de Efectividad Clinica Y Sanitaria Asociacion Civil</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2019-05-02"></transaction-date>
   <value currency="CAD" value-date="2019-05-02">130200</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="ES">IECS - Instituto de Efectividad Clinica Y Sanitaria Asociacion Civil</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2019-09-10"></transaction-date>
   <value currency="CAD" value-date="2019-09-10">130000</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="ES">IECS - Instituto de Efectividad Clinica Y Sanitaria Asociacion Civil</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="CAD" value-date="2020-03-31">-748220</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="ES">IECS - Instituto de Efectividad Clinica Y Sanitaria Asociacion Civil</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="CAD" value-date="2020-03-31">154820</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="ES">IECS - Instituto de Efectividad Clinica Y Sanitaria Asociacion Civil</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="CAD" value-date="2020-03-31">748220</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="ES">IECS - Instituto de Efectividad Clinica Y Sanitaria Asociacion Civil</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Grant is conditional on completion of specified terms of reference, receipt of specified deliverables</narrative>
    <narrative xml:lang="FR">La bourse est octroy&#xE9;e &#xE0; condition de respecter le mandat &#xE9;tabli et de livrer les r&#xE9;sultats attendus</narrative>
   </condition>
   <condition type="3">
    <narrative xml:lang="EN">Grant is conditional on periodic submission of a detailed accounting of expenditure of funds received from IDRC accompanied by estimation of budget for the next reporting period</narrative>
    <narrative xml:lang="FR">La bourse est octroy&#xE9;e &#xE0; condition de p&#xE9;riodiquement pr&#xE9;senter une justification d&#xE9;taill&#xE9;e de l&apos;utilisation des fonds vers&#xE9;s par le CRDI ainsi qu&apos;une estimation budg&#xE9;taire de la p&#xE9;riode de rapport suivante</narrative>
   </condition>
  </conditions>
 </iati-activity>
</iati-activities>
